Osnat Ron-Tal Fisher1, Ian M Gralnek2, Glenn M Eisen3, J Luke Williams4, Jennifer L Holub4. 1. Bruce and Ruth Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. 2. Bruce and Ruth Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel; GI Outcomes Unit, Department of Gastroenterology, Rambam Health Care Campus, Haifa, Israel. 3. Oregon Health & Science University, Department of Gastroenterology, Portland, Oregon, USA; The Oregon Clinic, Portland, Oregon, USA. 4. Oregon Health & Science University, Department of Gastroenterology, Portland, Oregon, USA.
Abstract
BACKGROUND: Data on the use of endoscopic hemostasis performed during colonoscopy for hematochezia are primarily derived from expert opinion and case series from tertiary care settings. OBJECTIVES: To characterize patients with hematochezia who underwent in-patient colonoscopy and compare those who did and did not receive endoscopic hemostasis. DESIGN: Retrospective analysis. SETTING: Clinical Outcomes Research Initiative National Endoscopic Database, 2002 to 2008. PATIENTS: Adults with hematochezia. INTERVENTIONS: None. MAIN OUTCOME MEASUREMENTS: Demographics, comorbidities, practice setting, adverse events, and colonoscopy procedural characteristics and findings. RESULTS: We identified 3151 persons who underwent in-patient colonoscopy for hematochezia. Endoscopic hemostasis was performed in 144 patients (4.6%). Of those who received endoscopic hemostasis, the majority were male (60.3%), white (83.3%), and older (mean age 70.9 ± 12.3 years); had a low-risk American Society of Anesthesiologists classification (53.9%); and underwent colonoscopy in a community setting (67.4%). The hemostasis-receiving cohort was significantly more likely to be white (83.3% vs 71.0%, P = .02), have more comorbidities (classes 3 and 4, 46.2% vs 36.0%, P = .04), and have the cecum reached (95.8% vs 87.7%, P = .003). Those receiving hemostasis were significantly more likely to have an endoscopic diagnosis of arteriovenous malformations (32.6% vs 2.6%, P = .0001) or a solitary ulcer (8.3% vs 2.1%, P < .0001). LIMITATIONS: Retrospective database analysis. CONCLUSIONS: Less than 5% of persons presenting with hematochezia and undergoing inpatient colonoscopy received endoscopic hemostasis. These findings differ from published tertiary care setting data. These data provide new insights into in-patient colonoscopy performed primarily in a community practice setting for patients with hematochezia.
BACKGROUND: Data on the use of endoscopic hemostasis performed during colonoscopy for hematochezia are primarily derived from expert opinion and case series from tertiary care settings. OBJECTIVES: To characterize patients with hematochezia who underwent in-patient colonoscopy and compare those who did and did not receive endoscopic hemostasis. DESIGN: Retrospective analysis. SETTING: Clinical Outcomes Research Initiative National Endoscopic Database, 2002 to 2008. PATIENTS: Adults with hematochezia. INTERVENTIONS: None. MAIN OUTCOME MEASUREMENTS: Demographics, comorbidities, practice setting, adverse events, and colonoscopy procedural characteristics and findings. RESULTS: We identified 3151 persons who underwent in-patient colonoscopy for hematochezia. Endoscopic hemostasis was performed in 144 patients (4.6%). Of those who received endoscopic hemostasis, the majority were male (60.3%), white (83.3%), and older (mean age 70.9 ± 12.3 years); had a low-risk American Society of Anesthesiologists classification (53.9%); and underwent colonoscopy in a community setting (67.4%). The hemostasis-receiving cohort was significantly more likely to be white (83.3% vs 71.0%, P = .02), have more comorbidities (classes 3 and 4, 46.2% vs 36.0%, P = .04), and have the cecum reached (95.8% vs 87.7%, P = .003). Those receiving hemostasis were significantly more likely to have an endoscopic diagnosis of arteriovenous malformations (32.6% vs 2.6%, P = .0001) or a solitary ulcer (8.3% vs 2.1%, P < .0001). LIMITATIONS: Retrospective database analysis. CONCLUSIONS: Less than 5% of persons presenting with hematochezia and undergoing inpatient colonoscopy received endoscopic hemostasis. These findings differ from published tertiary care setting data. These data provide new insights into in-patient colonoscopy performed primarily in a community practice setting for patients with hematochezia.
Keywords:
AE; ASA; AVM; American Society of Anesthesiologists; CORI; Clinical Outcomes Research Initiative; LGIB; NED; National Endoscopic Database; adverse event; arteriovenous malformation; lower GI bleeding
Authors: Fasiha Kanwal; Gareth Dulai; Dennis M Jensen; Ian M Gralnek; Thomas O g Kovacs; Gustavo A Machicado; Rome Jutabha Journal: Gastrointest Endosc Date: 2003-04 Impact factor: 9.427
Authors: Brintha K Enestvedt; Ian M Gralnek; Nora Mattek; David A Lieberman; Glenn Eisen Journal: Gastrointest Endosc Date: 2008-01-18 Impact factor: 9.427
Authors: Kathryn Oakland; Sandeepkumar Kothiwale; Tyler Forehand; Edmund Jackson; Cliff Bucknall; Michael S L Sey; Siddharth Singh; Vipul Jairath; Jonathan Perlin Journal: JAMA Netw Open Date: 2020-07-01
Authors: Tracey A Martin; Sunena Tewani; Lindsay Clarke; Aiya Aboubakr; Srikanth Palanisamy; Jihui Lee; Carl V Crawford; David W Wan Journal: Gastroenterology Res Date: 2021-07-28